Department of Exercise Medicine and Cardiovascular Rehabilitation, Palacký University Olomouc and University Hospital Olomouc, 77520 Olomouc, Czech Republic.
Department of Internal Medicine, FRANZISKUS SPITAL GmbH, Landstraßer Hauptstraße 4a, 1030 Vienna, Austria.
Medicina (Kaunas). 2021 Jun 18;57(6):633. doi: 10.3390/medicina57060633.
The association of coronavirus disease 2019 (COVID-19) with hypertension has been one of the frequently discussed topics in current studies since hypertension was identified as a risk factor for coronavirus disease. However, no studies seem to be focused on the BP (blood pressure) in patients with hypertension after COVID-19.
This report presents the cases of five frail geriatric patients (avg. age 78.3 (±6.4) years) with sarcopenia and controlled hypertension (office BP < 140 mmHg) who were diagnosed with SARS-CoV-2.
Control ABPM performed after COVID-19 showed that these hypertensive patients were hypotensive and that the previously well-established therapy was suddenly too intensive for them.
These findings suggest that BP control after COVID-19 is needed and that ABPM is, particularly in frail geriatric patients, by no means a luxury but a necessity.
自高血压被确定为冠状病毒病的一个危险因素以来,2019 年冠状病毒病(COVID-19)与高血压之间的关联一直是当前研究中讨论较多的话题之一。然而,似乎没有研究关注 COVID-19 后高血压患者的血压(BP)。
本报告介绍了 5 例体弱的老年患者(平均年龄 78.3(±6.4)岁)的病例,这些患者患有肌少症和控制良好的高血压(诊室 BP<140mmHg),被诊断为 SARS-CoV-2 感染。
COVID-19 后进行的动态血压监测(ABPM)显示,这些高血压患者血压偏低,之前确立的治疗方案对他们来说突然过于强烈。
这些发现表明 COVID-19 后需要控制血压,特别是在体弱的老年患者中,ABPM 绝不是一种奢侈,而是一种必要。